1-800-TEMPLE-MED

Newsroom
Page size:
select
 607 items in 61 pages
 
Page size:
select
 607 items in 61 pages

Dr. William Auger Joins Temple as Chronic
Thromboembolic Pulmonary Hypertension Specialist


(Philadelphia, PA) – William R. Auger, MD, has joined Temple University Hospital as a pulmonologist in the Pulmonary Hypertension, Right Heart Failure and Chronic Thromboembolic Pulmonary Hypertension (CTEPH) Program in the Temple Heart and Vascular Institute, and Clinical Professor of Medicine at the Lewis Katz School of Medicine at Temple University.
read more »

Lewis Katz School of Medicine at Temple University and
Hunter College of the City University of New York Awarded
$13.5 Million NCI/NIH Grant for Cancer Health Disparities


(Philadelphia, PA) – The Lewis Katz School of Medicine at Temple University (LKSOM) and Hunter College of the City University of New York (Hunter) have jointly received a five-year, $13.5 million grant from the National Cancer Institute (NCI). The award will underwrite creation of the Temple University Fox Chase Cancer Center (TUFCCC) and Hunter College (HC) Regional Comprehensive Cancer Health Disparities Partnership.
read more »

New Epigenetic Drug Strategy to Treat Cancer


(Philadelphia, PA) – A team led by researchers at the Lewis Katz School of Medicine at Temple University has discovered that inhibiting CDK9, a DNA transcription regulator, reactivates genes that have been epigenetically silenced by cancer. Reactivation leads to restored tumor suppressor gene expression and enhanced anti-cancer immunity. It is the first time this particular kinase has been linked to gene silencing in mammals.
read more »

Temple Lung Center Director Reports
Continued Positive Results for Study Examining
Minimally Invasive Treatment of Severe Emphysema


(Philadelphia, PA) – Dr. Gerard Criner, MD, FACP, FACCP, Chair and Professor of Thoracic Medicine and Surgery at the Lewis Katz School of Medicine at Temple University, announced the 12-month results of the EMPROVE multicenter, randomized and controlled study for the Spiration® Valve System (SVS), a minimally invasive treatment for severe emphysema, at the European Respiratory Society International Congress (ERS) in Paris, France, on Sept. 18.
read more »

Dr. Cecelia Schmalbach Appointed The Inaugural David Myers, MD Professor and Chair in Otolaryngology-Head and Neck Surgery at the Lewis Katz School of Medicine at Temple University


(Philadelphia, PA) – Cecelia E. Schmalbach, MD, MSc, FACS, has been appointed The David Myers, MD Professor and Chair in Otolaryngology-Head and Neck Surgery at the Lewis Katz School of Medicine at Temple University, effective October 1, 2018. This newly-endowed Chair honoring Dr. David Myers, a former Chair of Temple Otorhinology, will support in perpetuity the department’s excellence and innovation in clinical care, research, and medical training.
read more »

Temple Scientists Identify Genetic Variants Almost Exclusive to African Americans That Predict Poor Outcomes in Dilated Cardiomyopathy Heart Disease


(Philadelphia, PA) – Genetic testing is a powerful diagnostic tool that is increasingly being used for the diagnosis of dilated cardiomyopathy, a disease in which the heart becomes enlarged, making it difficult to pump blood. Cardiomyopathy affects more than 3.5 million people in the United States. African Americans are at especially high risk but have been underrepresented in genetic studies, often due to socioeconomic barriers and other health disparities. Now, after years of work, researchers at the Lewis Katz School of Medicine at Temple University have identified four variations in a gene known as BAG3 that are linked to a poor outcome.
read more »

Temple University Hospital Performs Nation’s First
Post-FDA Approval Bronchoscopic Lung Volume
Reduction Using Implantation of the Zephyr®
Endobronchial Valve to Treat Severe Emphysema


(Philadelphia, PA) – Temple University Hospital has become the first U.S. center to perform bronchoscopic lung volume reduction using implantation of the Zephyr® Endobronchial Valve (Zephyr® EBV®) to treat severe emphysema following U.S. FDA approval.
read more »

Dr. Thomas Fekete Appointed Chair of Medicine
at the Lewis Katz School of Medicine at Temple University


(Philadelphia, PA) – Thomas Fekete, MD, has been appointed Chair of Medicine at the Lewis Katz School of Medicine at Temple University. Dr. Fekete has served as Interim Chair of Medicine since November 2017.
read more »

Temple-Led Research Calls into Question the Effectiveness
of Inferior Vena Cava Filter Use in Patients Undergoing
Catheter-Directed Thrombolysis for Deep Vein Thrombosis


(Philadelphia, PA) – Deep vein thrombosis (DVT) is a common medical condition in which blood clots develop in the deep veins of the body, often in the legs, thigh or pelvis. These clots can break loose and travel to the lungs and can cause a life-threatening pulmonary embolism. Proximal DVT, which refers to a clot in the thigh or pelvis, has been shown to be associated with a higher risk for post-thrombotic syndrome, a painful condition characterized by swelling, redness and sores on the legs.
read more »

Temple University Hospital Offering First FDA-Approved
Minimally Invasive Bronchoscopic Treatment for Emphysema


(Philadelphia, PA) – Last month, a Temple University Hospital-led research team reported that implantation of the Zephyr® Endobronchial Valve (Zephyr® EBV®) successfully reduced shortness of breath and improved lung function and quality of life, with benefits lasting at least one-year post-intervention for patients with severe emphysema. The results of that clinical trial, known as LIBERATE, were presented at the ATS International Conference and published simultaneously in the American Journal of Respiratory and Critical Care Medicine. Having completed a review of the study results, the U.S. Food and Drug Administration has today granted pre-market approval under its breakthrough devices designation to the Zephyr® EBV® to treat breathing difficulty associated with severe emphysema.
read more »